Here, we identified in vivo a Nod1-dependent mechanism that intrinsically activates a signaling cascade previously only associated with classical inflammation, that initiates within the ECs to drive HE fate, a pre-requisite for HSPC specification. The gene discussed is NOD1; the disease is hereditary elliptocytosis.